These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35067829)

  • 1. Olfactory Bulb Excitotoxicity as a Gap-Filling Mechanism Underlying the Link Between Traumatic Brain Injury-Induced Secondary Neuronal Degeneration and Parkinson's Disease-Like Pathology.
    Marin C; Fuentes M; Alobid I; Tubita V; Rojas-Lechuga MJ; Mullol J
    Neurochem Res; 2022 Apr; 47(4):1025-1036. PubMed ID: 35067829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory function in an excitotoxic model for secondary neuronal degeneration: Role of dopaminergic interneurons.
    Marin C; Laxe S; Langdon C; Berenguer J; Lehrer E; Mariño-Sánchez F; Alobid I; Bernabeu M; Mullol J
    Neuroscience; 2017 Nov; 364():28-44. PubMed ID: 28918258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons.
    Marin C; Laxe S; Langdon C; Alobid I; Berenguer J; Fuentes M; Bernabeu M; Mullol J
    Mol Neurobiol; 2019 Dec; 56(12):8063-8075. PubMed ID: 31177483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.
    Sharma M; Kaur J; Rakshe S; Sharma N; Khunt D; Khairnar A
    Neurotox Res; 2022 Feb; 40(1):215-229. PubMed ID: 34817799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.
    Acosta SA; Tajiri N; de la Pena I; Bastawrous M; Sanberg PR; Kaneko Y; Borlongan CV
    J Cell Physiol; 2015 May; 230(5):1024-32. PubMed ID: 25251017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.
    Niu H; Wang Q; Zhao W; Liu J; Wang D; Muhammad B; Liu X; Quan N; Zhang H; Zhang F; Wang Y; Li H; Yang R
    Brain Pathol; 2020 Nov; 30(6):1102-1118. PubMed ID: 32678959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of Olfactory Function After Excitotoxic Lesion of the Olfactory Bulbs Is Associated with Increases in Bulbar SIRT1 and SIRT4 Expressions.
    Marin C; Langdon C; Alobid I; Fuentes M; Bonastre M; Mullol J
    Mol Neurobiol; 2019 Aug; 56(8):5643-5653. PubMed ID: 30661205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic Lesion in the Olfactory Bulb Restores Olfaction and Induces Depressive-Like Behaviors in a 6-OHDA Model of Parkinson's Disease.
    Ilkiw JL; Kmita LC; Targa ADS; Noseda ACD; Rodrigues LS; Dorieux FWC; Fagotti J; Dos Santos P; Lima MMS
    Mol Neurobiol; 2019 Feb; 56(2):1082-1095. PubMed ID: 29869198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson's Disease.
    Guatteo E; Berretta N; Monda V; Ledonne A; Mercuri NB
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and Neuroimmune Interactions Underlying Parkinson's Disease and Traumatic Brain Injury.
    Lillian A; Zuo W; Laham L; Hilfiker S; Ye JH
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
    Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
    Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal, spatial and molecular pattern of dopaminergic neurodegeneration in the AAV-A53T α-synuclein rat model of Parkinson's disease.
    Musacchio T; Yin J; Kremer F; Koprich JB; Brotchie JM; Volkmann J; Ip CW
    Behav Brain Res; 2022 Aug; 432():113968. PubMed ID: 35738338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
    Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
    Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease.
    Morales I; Sabate M; Rodriguez M
    Eur J Neurosci; 2013 Jul; 38(1):2172-82. PubMed ID: 23565852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
    Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
    Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders.
    Wise RM; Wagener A; Fietzek UM; Klopstock T; Mosharov EV; Zucca FA; Sulzer D; Zecca L; Burbulla LF
    Neurobiol Dis; 2022 Dec; 175():105920. PubMed ID: 36351559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
    Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.